Biochemical analysis of pleural, peritoneal and pericardial effusions

Clinica Chimica Acta

Volumn 343, Issue 1-2, 2004, Pages 61-84

  Burgess, L J ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Biochemical analysis; Pericardial effusions; Peritoneal fluids; Pleural fluids

Indexed keywords

ADENOSINE DEAMINASE; AMYLASE; BIOLOGICAL MARKER; CHOLESTEROL; GLUCOSE; LACTATE DEHYDROGENASE; LIPID; TUMOR MARKER;

ASCITES; ASCITES FLUID; BLOOD ANALYSIS; BODY FLUID; CEREBROSPINAL FLUID ANALYSIS; EXUDATE; HUMAN; LABORATORY TEST; PATHOPHYSIOLOGY; PERICARDIAL EFFUSION; PERICARDITIS; PERITONEAL FLUID; PERITONEUM EXUDATE; PH; PLEURA EFFUSION; PLEURA FLUID; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PRIORITY JOURNAL; REVIEW; STRUCTURE ANALYSIS; TUBERCULOSIS; TUBERCULOUS PERITONITIS; URINALYSIS;

ASCITIC FLUID; HUMANS; PERICARDIAL EFFUSION; PLEURAL DISEASES; TUMOR MARKERS, BIOLOGICAL;

EID: 2042545439     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2004.02.002     Document Type: Review

References (262)

1. Black L.F. The pleural space and pleural fluid. Mayo Clin. Proc. 47:1972;493-506
2. Light R.W. Pleural diseases. 4th edition:2001;Lippincott Williams and Wilkins, Philadelphia
3. Peterman T.A., Brothers S.K. Pleural effusions in congestive heart failure and in pericardial disease. N. Engl. J. Med. 309:1983;313
4. Collins T.R., Sahn S.A. Thoracentesis: clinical value, complications, technical problems and patient experience. Chest. 91:1987;817-822
5. Sahn S.A. Pleural fluid analysis: narrowing the differential diagnosis. Semin. Respir. Med. 9:1987;22-29
6. Seneff M.G., Corwin R.W., Gold L.H., et al. Complications associated with thoracentesis. Chest. 90(1):1986;97-100
7. Jones P.W., Moyers J.P., Rogers J.T., et al. Ultrasound-guided thoracentesis; is it a safer method? Chest. 123:2003;418-423
8. Jay S.J. Diagnostic procedures for pleural disease. Clin. Chest Med. 6:1985;33-48
9. Light R.W., Erozan Y.S., Ball W.C. Jr. Cells in pleural fluid: their value in differential diagnosis. Arch. Intern. Med. 132:1973;854-860
10. Sahn S.A. The pleura: state of the art. Am. Rev. Respir. Dis. 138:1988;184-234
11. Sassoon C.S., Light R.W. Chylothorax and pseudochylothorax. Clin. Chest Med. 6:1985;163-171
12. Staats B.A., Ellefson R.D., Budahn L.L., et al. The lipoprotein profile of chylous and non-chylous pleural effusions. Mayo Clin. Proc. 55:1980;700-704
13. Lyche K.D., Jensen W.A., Kirsch C.M., et al. Pleuropulmonary manifestations of hepatic amebiasis. West. J. Med. 153:1990;275-278
14. Rasmussen K.N., Faber V. Hyaluronic acid in 247 pleural fluids. Scand. J. Respir. Dis. 48:1967;366-371
15. Paddock F.K. The diagnostic significance of serous fluids in disease. N. Engl. J. Med. 223:1940;1010-1015
16. Light R.W. Clinical practice: pleural effusion. N. Engl. J. Med. 346:2002;1971-1977
17. Burgess L.J., Maritz F.J., Taljaard F.F.J. Epidemiology of pleural effusions (Letter). S. Afr. Med. J. 86(2):1996;186
18. Peterman T.A., Speicher C.E. Evaluating pleural effusions: a two-stage laboratory approach. JAMA. 252:1984;1051-1053
19. Carr D.T., Power M.H. Clinical value of measurement of concentration of protein in pleural fluid. N. Engl. J. Med. 259:1958;926-927
20. Chandrasekhar A.J., Palatao A., Dubin A., Levine H. Pleural fluid lactic acid dehydrogenase activity and protein content. Arch. Intern. Med. 123:1969;48-50
21. Light R.W., MacGregor M.I., Luchsinger P.C., Ball W.C. Pleural effusions: the diagnostic separation of transudates and exudates. Ann. Intern. Med. 77:1972;507-513
22. Hirsch A., Ruffie P., Nebut M. Pleural effusion: laboratory tests in 300 cases. Thorax. 34:1979;106-112
23. Roth B.J., O'Meara T.F., Cragun W.H. The serum-effusion albumin gradient in the evaluation of pleural effusions. Chest. 98:1990;546-549
24. Tarn A.C., Lapworth R. Biochemical analysis of pleural fluid: what should we measure? Ann. Clin. Biochem. 38:2001;311-322
25. Heffner J.E., et al. for the Primary Study Investigators Diagnostic value of tests that discriminate between exudative and transudative pleural effusions. Chest. 111:1997;970-980
26. Light R.W. Pleural diseases. 1983;Lea & Febiger, Philadelphia (PA)
27. Romero S., Candela A., Martin C., et al. Evaluation of different criteria for the separation of pleural transudates from exudates. Chest. 104:1993;399-404
28. Vives M., Porcel J.M., Vincente de Vera M., et al. A study of Light's criteria and possible modifications for distinguishing exudative from transudative pleural effusions. Chest. 109:1996;1503-1507
29. Burgess L.J., Maritz F.J., Taljaard J.J.F. Comparative analysis of the biochemical parameters used to differentiate between pleural transudates and exudates. Chest. 107:1995;1604-1609
30. Pillay U.K.G. Total proteins in serous fluids in cardiac failure. S. Afr. Med. J. 39:1965;142-143
31. Chakko S.C., Caldwell S.H., Sforza P.P. Treatment of congestive heart failure: its effect on pleural fluid chemistry. Chest. 95:1989;798-802
32. Broaddus V.C., Light R.W. What is the origin of pleural transudates and exudates. Chest. 102:1992;658-659
33. Pistolesi M., Miniati M., Guintini C. Pleural liquid and solute exchange. Am. Rev. Respir. Dis. 140:1989;825-847
34. Zinneman H.H., Johnson J.J., Lyon R.H. Proteins and microproteins in pleural effusions. Am. Rev. Respir. Dis. 76:1957;247-255
35. Shallenberger D.W., Daniel T.M. Quantitative determination of several pleural fluid proteins. Am. Rev. Respir. Dis. 106:1972;121-122
36. Broaddus V.C., Staub N.C. Pleural liquid and protein turnover in health and disease. Semin. Respir. Med. 9:1987;7-12
37. Heffner J.E., Nietert P.J., Barbieri C. Pleural fluid pH as a predictor for patients with malignant pleural effusions. Chest. 117(1):2000;79-86
38. Hamm H., Brohan U., Bohmer R., Missmahl H.P. Cholesterol in pleural effusions. A diagnostic aid. Chest. 92:1987;296-302
39. Valdés L., Pose A., Suarez J., et al. Cholesterol: a useful parameter for distinguishing between pleural exudates and transudates. Chest. 99:1991;1097-1102
40. Costa M., Quiroga T., Cruz E. Measurement of pleural fluid cholesterol and lactate dehydrogenase. A simple and accurate set of indicators for separating exudates from transudates. Chest. 108:1995;1260-1263
41. Meisel S., Shamis A., Thaler M., et al. Pleural fluid to serum bilirubin concentration ratio for the separation of transudates from exudates. Chest. 98:1990;141-144
42. Garcia-Pachon E., Padilla-Navas I., Sanchez J.F., et al. Pleural fluid to serum cholinesterase ratio for the separation of transudates and exudates. Chest. 110:1996;97-101
43. Garcia-Pachon E., Padilla-Navas I. Pleural to serum cholinesterase ratio in the separation of transudative and exudative pleural effusions. Chest. 110:1996;999
44. Metintas M., Alatas O., Alatas F., et al. Comparative analysis of biochemical parameters for differentiation of pleural exudates from transudates: light's criteria, cholesterol, bilirubin, albumin gradient, alkaline phosphatase, creatine kinase and uric acid. Clin. Chim. Acta. 264:1997;149-162
45. Burgess L.J., Taljaard J.J.F., Maritz F.J. A rapid screening test for pleural exudates. S. Afr. Med. J. 89:1999;14
46. Heffner J.E., Highland K., Brown L.K. A meta-analysis derivation of continuous likelihood ratios for diagnosing pleural fluid exudates. Am. J. Respir. Crit. Care Med. 167:2003;1591-1599
47. Zweig M.H., Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 39:1993;561-577
48. Sahn S.A. The differential diagnosis of pleural effusions. West. J. Med. 137:1982;99-108
49. Kjeldsberg C.R., Knight J.A. Body fluids. 3rd edition:1993;159-254 American Society of Clinical Pathologists Press, Chicago
50. Heffner J.E., Brown L.K., Barbieri C., DeLeo J.M. Pleural fluid chemical analysis in parapneumonic effusions: a meta-analysis. Am. J. Respir. Crit. Care Med. 151:1995;1700-1708. [Erratum, Am J Respir Crit Care Med 1995;152:823]
51. Light R.W., Ball W.C. Jr. Glucose and amylase in pleural effusions. JAMA. 225:1973;257-259
52. Rodriguez-Panadero F., Lopes-Mejias J. Low glucose and pH levels in malignant pleural effusions: diagnostic significance and prognostic value in respect to pleurodesis. Am. Rev. Respir. Dis. 139:1989;663-667
53. Berger H.W., Maher G. Decreased glucose concentration in malignant pleural effusions. Am. Rev. Respir. Dis. 103:1971;427-429
54. Calnan W.L., Winfield B.J.O., Crowley M.F., Bloom A. Diagnostic value of the glucose content of serous pleural effusions. BMJ. 1:1951;1239-1240
55. Carr D.T., Power M.H. Pleural fluid glucose with special reference to its concentration in rheumatoid pleurisy with effusion. Dis. Chest. 37:1960;321-324
56. Good J.T. Jr., Taryle D.A., Maulitz R.M., et al. The diagnostic value of pleural fluid pH. Chest. 78:1980;55-59
57. Colice G.L., Curtis A., Deslauriers J., et al. Medical and surgical treatment of parapneumonic effusions: an evidence-based guideline. Chest. 118:2000;1158-1171. [Erratum, Chest 2001;119:319]
58. Potts D.E., Levin D.C., Sahn S.A. Pleural fluid pH in parapneumonic effusions. Chest. 70:1976;328-331
59. Sahn S.A. Management of complicated parapneumonic effusions. Am. Rev. Respir. Dis. 148:1993;813-817
60. Heffner J.E., Nietert P.J., Barbieri C. Pleural fluid pH as a predictor of pleurodesis failure. Analysis of primary data. Chest. 117(1):2000;87-95
61. Sahn S.A., Good J.T. Jr. Pleural fluid pH in malignant effusions: diagnostic, prognostic, and therapeutic implications. Ann. Intern. Med. 108:1988;345-349
62. Good J.T., Taryle D.A., Sahn S.A. The pathogenesis of low glucose, low pH malignant effusions. Am. Rev. Respir. Dis. 131:1985;737-741
63. Rodriguez-Panadero F., Lopez Mejias J. Low glucose and pH levels in malignant pleural effusions: diagnostic significance and prognostic values in respect to pleurodesis. Am. Rev. Respir. Dis. 139:1989;663-667
64. Rodriguez-Panadero F., Lopez Mejias J. Survival time of patients with pleural metastatic carcinoma predicted by glucose and pH studies. Chest. 95:1989;320-324
65. Sanchez-Armengol A., Rodriguez-Panadero F. Survival and talc pleurodesis in metastatic pleural carcinoma revisited: report of 125 cases. Chest. 104:1993;1317-1319
66. Sahn S.A. Pleurodesis for malignant and nonmalignant pleural effusions. Clin. Pulm. Med. 6:1999;141-146
67. Foresti V., Scolari N., Villa A., et al. Malignant pleural effusions: meaning of pleural-fluid pH determination. Oncology. 47:1990;62-64
68. Heffner J.E., Heffner J.N., Brown L.K. Multilevel and continuous pleural fluid pH likelihood ratios for evaluating malignant pleural effusions. Chest. 123(6):2003;1887-1894
69. Potts D.E., Taryle D.A., Sahn S.A. The glucose-pH relationship in parapneumonic effusions. Arch. Intern. Med. 138:1978;1378-1380
70. Hill A.R. Avoiding air in pleural fluid pH samples. Chest. 113:1998;1729-1730
71. Byrd R.P. Jr., Roy T.M. Pleural fluid pH determination. Chest. 113:1998;1426-1427
72. Lesho E.P., Roth B.J. Is pH paper an acceptable, low-cost alternative to the blood gas analyser for determining pleural fluid pH? Chest. 112:1997;1291-1292
73. Seriff N.S., Cohen M.L., Samuel P., Schulster P.L. Chylothorax: diagnosis by lipoprotein electrophoresis of serum and pleural fluid. Thorax. 32:1977;98-100
74. Staats B.A., Ellefson R.D., Budahn L.L., et al. The lipoprotein profile of chylous and nonchylous pleural effusions. Mayo Clin. Proc. 55:1980;700-704
75. Seibert A.F., Haynes J. Jr., Middleton R., Bass J.B. Jr. Tuberculous pleural effusion: twenty-year experience. Chest. 99:1991;883-886
76. Piras M.A., Gakis C., Budroni M., Andreoni G. Adenosine deaminase activity in pleural effusions: an aid to differential diagnosis. BMJ. 2:1978;1751-1752
77. Maritz F.J., Malan C., Le Roux I. Adenosine deaminase estimations in the differentiation of pleural effusions. S. Afr. Med. J. 62:1982;556-558
78. Ocaña I., Martinez-Vazquez J.M., Segura R.M., et al. Adenosine deaminase in pleural fluids: test for diagnosis of tuberculous pleural effusion. Chest. 84:1983;51-53
79. Pettersson T., Ojala K., Weber T.H. Adenosine deaminase in the diagnosis of pleural effusions. Acta Med. Scand. 215:1984;299-304
80. Strankinga W.F.M., Nauta J.J., Straub J.P., Stam J. Adenosine deaminase activity in tuberculous pleural effusions: a diagnostic test. Tubercle. 68:1987;137-140
81. Bañales J.L., Pineda P.R., Fitzgerald J.M., et al. Adenosine deaminase in the diagnosis of tuberculous pleural effusions: a report of 218 patients and review of the literature. Chest. 99:1991;355-357
82. San José E., Valdés L., Sarandeses A., et al. Diagnostic value of adenosine deaminase and lysozyme in tuberculous pleurisy. Clin. Chim. Acta. 209:1992;73-81
83. Valdés L., San José E., Alvarez D., et al. Diagnosis of tuberculous pleurisy using the biologic parameters adenosine deaminase, lysozyme and interferon gamma. Chest. 103:1993;458-465
84. Burgess L.J., Maritz F.J., Le Roux I., Taljaard J.J.F. Use of adenosine deaminase as a diagnostic tool for tuberculous pleurisy. Thorax. 50:1995;672-674
85. Van Keimpema A.R.J., Slaats E.H., Wagenaar J.P.M. Adenosine deaminase, not diagnostic for tuberculous pleurisy. Eur. J. Respir. Dis. 71:1987;15-18
86. Maartens G., Bateman E.D. Tuberculous pleural effusions: increased culture yield with bedside inoculation of pleural fluid and poor diagnostic value of adenosine deaminase. Thorax. 46:1991;96-99
87. Burgess L.J., Maritz F.J., Le Roux I., Taljaard J.J.F. Combined use of pleural adenosine deaminase with lymphocyte/neutrophil ratio. Increased specificity for the diagnosis of tuberculous pleuritis. Chest. 109:1996;414-419
88. Baganha M.F., Pego A., Lima M.A., et al. Serum and pleural adenosine deaminase: correlation with lymphocytic populations. Chest. 97:1990;605-610
89. Bovornkitti S., Pushpakom R., Maranetra N., et al. Adenosine deaminase and lymphocytic populations. Chest. 99:1991;789-790
90. Hirschhorn R., Ratech H. Isozymes of adenosine deaminase. Curr. Top. Biol. Med. Res. 4:1980;131-157
91. Ungerer J.P.J., Oosthuizen H.M., Bissbort S.H., Vermaak W.J.H. Serum adenosine deaminase: isoenzymes and diagnostic application. Clin. Chem. 38:1992;1322-1326
92. Valdés L., San José E., Alvarez D., Valle J.M. Adenosine deaminase (ADA) isoenzyme analysis in pleural effusions: diagnostic role, and relevance to the origin of increased ADA in tuberculous pleurisy. Eur. Respir. J. 9:1996;747-751
93. Ungerer J.P.J., Oosthuizen H.M., Retief J.H., Bissbort S.H. Significance of adenosine deaminase activity and its isoenzymes in tuberculous effusions. Chest. 106:1994;33-37
94. Carstens M.E., Burgess L.J., Maritz F.J., Taljaard J.J.F. Isoenzymes of adenosine deaminase in pleural effusions: a diagnostic tool? Int. J. Tuberc. Lung Dis. 2:1998;1-5
95. Gakis C., Calia G., Naitana A., et al. Serum adenosine deaminase activity in HIV positive subjects: a hypothesis of the significance of ADA2. Panminerva Med. 31:1989;107-113
96. Gakis C., Calia G., Naitana A., et al. Serum and pleural adenosine deaminase activity; correct interpretation of the findings. Chest. 99:1991;1555-1556
97. + T lymphocyte subpopulation in tuberculous pleuritis. J. Immunol. 142:1989;1114-1119
98. Shimokata K., Saka H., Murate T., et al. Cytokine content in pleural effusion: comparison between tuberculous and carcinomatous pleurisy. Chest. 99:1991;1103-1107
99. Aoki Y., Katoh O., Nakanishi Y., et al. A comparison study of IFN-γ, ADA and CA-125 as the diagnostic parameters in tuberculous pleuritis. Respir. Med. 88:1994;139-143
100. Baig M.M., Pettengell K.E., Simgee A.E., et al. Diagnosis of tuberculosis by detection of mycobacterial antigens in pleural effusions and ascites. S. Afr. Med. J. 69:1986;101-102
101. Yew W.W., Chan C.Y., Kwan S.Y., et al. Diagnosis of tuberculous pleural effusion by the detection of tuberculostearic acid in pleural aspirates. Chest. 100:1991;1261-1263
102. Dhand R., Ganguly N.K., Vaishnavi C., et al. False-positive reactions with enzyme-linked immunosorbent assay of Mycobacterium tuberculosis antigens in pleural fluid. J. Med. Microbiol. 26:1988;241-243
103. Levy H., Wayne L.G., Anderson B.E., et al. Anti-mycobacterial antibody levels in pleural fluid as reflection of passive diffusion from serum. Chest. 92:1989;1144-1147
104. Van Vooren J.P., Farber C.M., De Bruyn J., Yernault J.C. Antimycobacterial antibodies in pleural effusions. Chest. 97:1990;88-90
105. Murate T., Mizoguchi K., Amano H., et al. Antipurified-Protein-Derivative antibody in tuberculous pleural effusions. Chest. 97:1990;670-673
106. Caminero J.A., Rodriquez de Castro F., Carrillo T., et al. Diagnosis of pleural tuberculosis by detection of specific IgG anti-antigen 60 in serum and pleural fluid. Respiration. 60:1993;58-62
107. Berger H.W., Mejia E. Tuberculous pleurisy. Chest. 63:1973;88-92
108. Epstein D.M., Kline L.R., Albelda S.M., Miller W.T. Tuberculous pleural effusions. Chest. 91:1987;106-109
109. Chavalittamrong B., Angsusingha K., Tuchinda M., et al. Diagnostic significance of pH, lactic acid dehydrogenase, lactate and glucose in pleural fluid. Respiration. 38:1979;112-120
110. Barnes P.F., Modlin R.L., Bikle D.D., Adams J.S. Transpleural gradient of 1.25-dihydroxyvitamin D in tuberculous pleuritis. J. Clin. Invest. 83:1989;1527-1532
111. Verea Hernando H.R., Masa Jimenez J.F., Donguez Juncal L., et al. Meaning and diagnostic value of determining the lysozyme level of pleural fluid. Chest. 91:1987;342-345
112. Niwa Y., Kishimoto H., Shimokata K. Carcinomatous and tuberculous pleural effusions; comparison of tumour markers. Chest. 87:1985;351-355
113. Tamura S., Nishigaki T., Moriwaki Y., et al. Tumor markers in pleural effusion diagnosis. Cancer. 61:1988;298-302
114. Rittgers R.A., Loewenstein M.S., Feinerman A.E., et al. Carcinoembryonic antigen levels in benign and malignant pleural effusions. Ann. Intern. Med. 88:1978;631-634
115. Klockars M., Lindgren J., Pettersson T., et al. Carcinoembryonic antigen in pleural effusions. Lancet. 2:1978;1057-1058
116. Salama G., Miedouge M., Rouzard P., et al. Evaluation of pleural CYFRA 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions. Br. J. Cancer. 77:1998;472-476
117. Milano G., Krebs B.P., Duplay H., et al. Use of tumour markers as a supplement to cytology in diagnosis of malignant effusions. Clin. Chem. 26:1980;1632
118. Garcia-Pachon E., Padilla-Navas I., Dosda D., Miralles-Llopis A. Elevated level of carcinoembryonic antigen in non-malignant pleural effusions. Chest. 111:1997;643-647
119. Conejo J.R., Benedito J.E., Jiminez A., et al. Diagnostic value of three tumor markers determined in pleural effusions. Eur. J. Clin. Chem. Biochem. 34:1996;139-142
120. San José N.E., Alvarez D., Valdés L., et al. Utility of tumour markers in the diagnosis of neoplastic pleural effusion. Clin. Chim. Acta. 265:1997;193-205
121. Mezger J., Permanetter W., Gerbes A.L., et al. Tumour-associated antigens in diagnosis of serous effusions. J. Clin. Pathol. 41:1988;633-643
122. Pettersson T., Klockars M., Froseth B. Neuron-specific enolase in the diagnosis of small-cell lung cancer with pleural effusion: a negative report. Eur. Respir. J. 1:1988;698-700
123. Shimokata K., Niwa Y., Yamamoto M., et al. Pleural fluid neuron-specific enolase: a useful diagnostic marker for small cell lung cancer pleurisy. Chest. 95:1989;602-603
124. Lee Y.C., Knox B.S., Garrett J.E. Use of cytokeratin fragments 19.1 and 19.21 (Cyfra 21-1) in the differentiation of malignant and benign pleural effusions. Aust. N. Z. J. Med. 29:1999;765-769
125. Marel M., Stastny B., Melinova L., et al. Diagnosis of pleural effusions: experience with clinical studies, 1986-1990. Chest. 107:1995;1598-1603
126. Pettersson T., Weber T.H., Ojala K. Creatine kinase isoenzyme BB as a tumor marker in pleural effusions. Clin. Chem. 27:1981;1147-1148
127. Vergnon J.M., Guidollet J., Gateau O., et al. Lactic dehydrogenase isoenzyme electrophoretic patterns in the diagnosis of pleural effusion. Cancer. 54:1984;507-511
128. Lossos I.S., Breuer R., Intrator O., Sonenblick M. Differential diagnosis of pleural effusion by lactate dehydrogenase isoenzyme analysis. Chest. 111:1997;648-651
129. Dines D.E., Elveback L.R., McCall J.T. Zinc, copper and iron content in benign and neoplastic disease. Thorax. 27:1972;368-370
130. Shepherd K.E. Diagnostic value of serum to pleural zinc ratios in pleural effusions. Chest. 95:1989;707
131. Branca P., Rodriguez R.M., Rogers J.T., et al. Routine measurement of pleural fluid amylase is not indicated. Arch. Intern. Med. 161:2001;228-232
132. Kaye M.D. Pleuropulmonary complications of pancreatitis. Thorax. 23:1968;297-306
133. Light R.W. Exudative pleural effusions secondary to gastrointestinal disease. Clin. Chest Med. 6:1985;103-111
134. Kramer M.R., Saldana M.J., Cepero R.J., Pitchenik A.E. High amylase in neoplasm-related pleural effusions. Ann. Intern. Med. 110:1989;567-569
135. Alexandrakis M., Coulocheri S., Kyriakou D., et al. Diagnostic vale of ferritin, haptoglobin, alpha-1-antitrypsin, lactate dehydrogenase and complement factors C3 and C4 in pleural effusion differentiation. Respir. Med. 91:1997;517-523
136. Telvi L., Jaubert F., Eyquem A., et al. Study of immunoglobulins in pleura and pleural effusions. Thorax. 34:1979;389-392
137. Asseo P.P., Tracopoulos G.D. Orosomucoid, α2-macroglobulin and immunoglobulins in serum and pleural effusions. Am. J. Clin. Pathol. 76:1981;437-441
138. Mak T.W.L., Ho S.S., Ho C.S., et al. Pleural fluid pseudouridine in malignant and benign pleural effusions. Ann. Clin. Biochem. 35:1998;94-98
139. Raja O.G., Casson I.F. Fibrinogen degradation products in pleural effusions. Br. J. Dis. Chest. 74:1980;164-168
140. 2- microglobulin in pleural effusions. Acta Med. Scand. 211:1982;45-50
141. Yinnon A., Konijn A.M., Link G., et al. Diagnostic value of ferritin in malignant pleural and peritoneal effusions. Cancer. 62:1988;2564-2568
142. Paydas S., Sargin O., Ozbek S., Gurbuz E. Ferritin levels in malignant effusions: a useful marker? Eur. J. Cancer. 26:1990;919
143. Brook I. Measurement of lactic acid in pleural fluid. Respiration. 40:1980;344-348
144. Stark D.D., Shanes J.G., Baron R.L., Koch D. Biochemical feature of urinotrax. Arch. Intern. Med. 142:1982;1509-1511
145. Marshall J.B. Finding the cause of ascites: the importance of accurate fluid analysis. Postgrad. Med. 83:1988;189-198
146. McHutchison J.G. Differential diagnosis of ascites. Semin. Liver Dis. 17:1997;191-202
147. Runyon B.A., Hoefs J.C. Is the concept of "exudative" ascites useful"? Hepatology. 4:1984;982
148. Runyon B.A. Care of patients with ascites. N. Engl. J. Med. 330:1994;337-342
149. Al-Knawy B.A. Etiology of ascites in the diagnostic value of serum-ascites albumin gradient in non-alcoholic liver disease. Ann. Saudi Med. 17:1997;26-28
150. Krige J.E.J., Beckingham I.J. Portal hypertension-2. Ascites, encephalopathy, and other conditions. BMJ. 322:2001;416-418
151. Ginès P., Quintero E., Arroyo V., et al. Compensated cirrhosis: natural history and prognostic factors. Hepatology. 7:1987;122-128
152. D'Amico G., Morabito A., Pagliaro L., Marubini E. Survival and prognostic indicators in compensated and decompensated cirrhosis. Dig. Dis. Sci. 31:1986;468-475
153. Nwokolo C. Ascites in Africa. BMJ. 1:1967;33-37
154. Menzies R.I., Alsen H., Fitzgerald J.M., Mohapeloa R.G. Tuberculous peritonitis in Lesotho. Tubercle. 67:1986;47-54
155. Caldwell S.H., Battle E.H. Ascites and spontaneous bacterial peritonitis. Schiff E.R., Sorrell M.F., Maddrey W.C. Schiff's diseases of the liver. 8th edition:1999;503-544 Lippincott-Raven, Philadelphia
156. Runyon B.A. Paracentesis of ascitic fluid: a safe procedure. Arch. Intern. Med. 146:1986;2259-2261
157. McVay P.A., Toy P.T.C.Y. Lack of increased bleeding after paracentesis and thoracentesis in patients with mild coagulation abnormalities. Transfusion. 31:1991;164-171
158. Garcia N. Jr., Sanyal A.J. Minimizing ascites. Postgrad. Med. 109:2001;91-103
159. Runyon B.A., Hoefs J.C., Morgan T.R. Ascitic fluid analysis in malignancy-related ascites. Hepatology. 8:1988;1104-1109
160. DeSitter L., Rector W.G. Jr. The significance of bloody ascites in patients with cirrhosis. Am. J. Gastroenterol. 79:1984;136-138
161. Manten H., Barkin J.S., Rogers A.I. Chylous ascites. Postgrad. Med. 71:1982;79-84
162. Runyon B.A. Ascitic fluid bilirubin concentration as a key to the diagnosis of choleperitoneum. J. Clin. Gastroenterol. 9:1987;543-545
163. Rovelstad R.A., Bartholomew L.G., Cain J.C., et al. The value of examination of ascitic fluid and blood for lipid and for proteins by electrophoresis. Gastroenterology. 34:1958;436-450
164. Runyon B.A., Montano A.A., Akriviadis E.A., et al. The serum-ascites albumin gradient is superior to the exudates-transudate concept in the differential diagnosis of ascites. Ann. Intern. Med. 117:1992;215-220
165. Sampliner R.E., Iber F.L. High protein ascites in patients with uncomplicated hepatic cirrhosis. Am. J. Med. Sci. 267:1974;275-279
166. Paré P., Talbot J., Hoefs J.C. Serum-ascites albumin concentration gradient: a physiological approach to the differential diagnosis of ascites. Gastroenterology. 85:1983;240-244
167. Hoefs J.C. Serum protein concentration and portal pressure determine the ascitic fluid protein concentration in patients with chronic liver disease. J. Lab. Clin. Med. 102:1983;260-273
168. Akriviadis E.A., Kapnias D., Hadjigavriel M., et al. Serum/ascites albumin gradient: its value as a rational approach to the differential diagnosis of ascites. Scand. J. Gastroenterol. 31:1996;814-817
169. Mauer K., Manzione N.C. Usefulness of serum-ascites albumin difference in separating transudative from exudative ascites: another look. Dig. Dis. Sci. 33:1988;1208-1212
170. Elis A., Meisel S., Tishler T., et al. Ascitic fluid to serum bilirubin concentration ratio for the classification of transudates or exudates. Am. J. Gastroenterol. 93:1998;401-403
171. Boyer T.D., Khan A.M., Reynolds T.B. Diagnostic value of ascitic fluid lactic dehydrogenase, protein, and WBC levels. Arch. Intern. Med. 138:1978;1103-1105
172. Goyal A.K., Goyal S.K., Pokharna D.S., Sharma S.K. Differential diagnosis of ascitic fluid: evaluation and comparison of various biochemical criteria with a special reference to serum ascites albumin concentration gradient and its relation to portal pressure. Trop. Gastroenterol. 10:1989;51-55
173. Gupta R., Misra S.P., Dwivedi M., et al. Diagnosing ascites: value of ascitic fluid total protein, albumin, cholesterol, their ratios, serum-ascites albumin and cholesterol gradient. J. Gastroenterol. Hepatol. 10:1995;295-299
174. Jüngst D., Gerbes A.L., Martin R., Paumgartner G. Value of ascitic lipids in the differentiation between cirrhotic and malignant ascites. Hepatology. 6:1986;239-243
175. Mortensen P.B., Kristensen S.D., Bloch A. Diagnostic value of ascitic fluid cholesterol levels in the prediction of malignancy. Scand. J. Gastroenterol. 23:1988;1085-1088
176. Pina-Cabral J.E., Correia-Leitão M., Guerra C., et al. Ascitic cholesterol: accurate parameter to the differential diagnosis of ascites (letter). Dig. Dis. Sci. 34:1989;964
177. Prieto M., Gómez-Léchon M.J., Hoyos M., et al. Diagnosis of malignant ascites: comparison of ascitic fibronectin, cholesterol and serum-ascites albumin difference. Dig. Dis. Sci. 33:1988;833-838
178. Alexandrakis M.G., Moschandrea J.A., Koulocheri S.A., et al. Discrimination between malignant and non-malignant ascites using serum and ascetic fluid proteins in a multivariate analysis model. Dig. Dis. Sci. 45(3):2000;500-508
179. Rector W.G. Jr., Reynolds T.B. Superiority of the serum-ascites albumin difference over the ascites total protein concentration in separation of "transudative" and "exudative" ascites. Am. J. Med. 77:1984;83-85
180. Kajani M.A., Yoo Y.K., Alexander J.A., et al. Serum-ascites albumin gradients in non-alcoholic lever disease. Dig. Dis. 35:1990;33-37
181. Viallet A., Joly J., Marleau D., et al. Comparison of free portal venous pressure and wedged hepatic venous pressure in patients with cirrhosis of the liver. Gastroenterology. 59:1970;372-375
182. Horn T., Christoffersen P., Henriksen J.H. Alcohol liver injury: defenestration in non cirrhotic livers. A scanning electron microscopic study. Hepatology. 7:1987;77-82
183. Hoefs J.C. Globulin correction of the albumin gradient: correlation with measured serum to ascites colloid osmotic pressure gradient. Hepatology. 16:1992;396-403
184. Stanley M.M., Ochi S., Lee K.K., et al. Peritoneovenous shunting as compared with medical treatment in patients with alcoholic cirrhosis and massive ascites. Veterans Cooperative study on Treatment of alcoholic cirrhosis with ascites. N. Engl. J. Med. 321:1989;1632-1638
185. Runyon B.A. Cardiac ascites: a characterization. J. Clin. Gastroenterol. 10:1988;410-412
186. Runyon B.A. Low-protein-concentration ascitic fluid is predisposed to spontaneous bacterial peritonitis. Gastroenterology. 91:1986;1343-1346
187. Soriano G., Guarner C., Teixido M., et al. Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology. 100:1991;477-481
188. Akriviadis E.A., Runyon B.A. Utility of an algorithm in differentiating spontaneous from secondary bacterial peritonitis. Gastroenterology. 98:1990;127-133
189. Runyon B.A., Hoefs J.C. Ascitic fluid analysis before, during and after spontaneous peritonitis. Hepatology. 5:1985;257-259
190. Shakil A.O., Korula J., Kanel G.C., et al. Diagnostic features of tuberculous peritonitis in the absence and presence of chronic liver disease: a case control study. Am. J. Med. 100:1996;179-185
191. Aalami O.O., Allen D.B., Organ C.H. Jr. Chylous ascites: a collective review. Surgery. 128:2000;761-778
192. Kelley M.L. Jr., Butt H.R. Chylous ascites: n analysis of its aetiology. Gastroenterology. 39:1960;161-170
193. Runyon B.A. Amylase levels in ascitic fluid. J. Clin. Gastroenterol. 9:1987;172-174
194. Corlette M.B., Dratch M., Sorger K. Amylase elevation attributable to an ovarian neoplasm. Gastroenterology. 74:1978;907-909
195. Runyon B.A., Hoefs J.C. Ascitic fluid analysis in the differentiation of spontaneous bacterial peritonitis from gastrointestinal tract perforation into ascitic fluid. Hepatology. 4:1984;447-450
196. Lowenstein M.S., Rittgers R.A., Feinterman A.E., et al. Carcinoembryonic antigen assay of ascites and detection of malignancy. Ann. Intern. Med. 88:1978;635-638
197. Scholmerich J., Volk B.A., Kottgen E. Fibronectin concentration in ascites differentiates between malignant and non-malignant ascites. Gastroenterology. 87:1984;1160-1164
198. Runyon B.A. Ascitic fluid "humoral test of malignancy" Hepatology. 6:1986;1443-1444
199. Runyon B.A. Elevated ascitic fluid fibronectin concentration: a non-specific finding. J. Hepatol. 3:1986;219-222
200. Voigt M.D., Kalvaria I., Trey C., et al. Diagnostic value of ascites adenosine deaminase in tuberculous peritonitis. Lancet. 1:1989;751-754
201. Hillebrand D.J., Runyon B.A., Yasmineh W.G., Rynders G.P. Ascitic fluid adenosine deaminase insensitivity in detecting tuberculous peritonitis in the United States. Hepatology. 24:1996;1408-1412
202. Blake J., Berman P. The use of adenosine deaminase assays in the diagnosis of tuberculosis. S. Afr. Med. J. 62:1982;19-21
203. Martinez-Vazquez J.M., Ocaña I., Ribera E., et al. Adenosine deaminase in the diagnosis of tuberculous peritonitis. Gut. 27:1986;1049-1053
204. Segura R.M., Pascual C., Ocaña I., et al. Adenosine deaminase in body fluids: a useful diagnostic tool in tuberculosis. Clin. Biochem. 22:1989;141-148
205. Bhargava D.K., Shriniwas M.O., Chopras P., et al. Peritoneal tuberculosis Laparoscopic patterns and its diagnostic accuracy. Am. J. Gastroenterol. 87:1992;109-112
206. Dwivedi M., Misra S.P., Misra V., Kumar R. Value of adenosine deaminase estimation in the diagnosis of tuberculous ascites. Am. J. Gastroenterol. 85:1990;1123-1125
207. Ribera E., Martinez-Vazquez J.M., Ocaña I., et al. Diagnostic value of ascites gamma interferon levels in tuberculous peritonitis: comparison with adenosine deaminase activity. Tubercle. 72:1991;193-197
208. Fernandez-Rodriguez C.M., Perez-Arguelles B.S., Ledo L., et al. Ascites adenosine deaminase activity is decreased in tuberculous ascites with low protein count. Am. J. Gastroenterol. 86:1991;1500-1503
209. Burgess L.J., Swanepoel C.G., Taljaard J.J.F. The use of adenosine deaminase as a diagnostic tool for peritoneal tuberculosis. Tuberculosis. 81:2001;243-248
210. Sathar M.A., Simjee A.E., Coovadia Y.M., et al. Ascitic fluid interferon concentrations and adenosine deaminase activity in tuberculous peritonitis. Gut. 36:1995;419-421
211. Nishida Y., Okudaira K., Tanimoto K., Akaoka I. The differences in purine metabolism between T and B lymphocytes. Exp. Hematol. 8:1980;593-598
212. Giron-Gonzalez J.A., Alvarez-Mon M., Menendez-Caro J.L., et al. T lymphocytes from alcoholic cirrhotic patients show normal interleukin-2 production but a defective proliferation response to polyclonal mitogens. Am. J. Gastroenterol. 89:1994;767-773
213. Sathar M.A., Ungerer J.P., Lockhat F., et al. Elevated adenosine deaminase activity in patients with HIV and tuberculous peritonitis. Eur. J. Gastroenterol. Hepatol. 11:1999;337-341
214. Runyon B.A., Antillon M.R. Ascitic fluid pH and lactate: insensitive and non-specific tests in detecting ascitic fluid infection. Hepatology. 13:1991;929-935
215. Albillos A., Cuervas-Mons V., Millan I., et al. Ascitic fluid polymorphonuclear cell count and serum to ascites albumin gradient in the diagnosis of bacterial peritonitis. Gastroenterology. 98:1990;134-140
216. Rush B.F. Jr., Host W.R., Fewel J., Hsieh J. Intestinal ischaemia and some organic substances in serum and abdominal fluid. Arch. Surg. 105:1972;151-157
217. Delany H.M., Moss C.M., Carnevale N. The use of enzyme analysis of
218. Marx J.A., Bar-Or D., Moore E.E., Tercier J.A. Utility of lavage alkaline phosphatase in detection of isolated small intestinal injury. Ann. Emerg. Med. 14:1985;10-14
219. Mansberger A.R. Jr. The diagnostic value of abdominal paracentesis with special reference to peritoneal fluid ammonia levels. Am. J. Gastroenterol. 42:1964;150-161
220. Brook I., Altman R.S., Lachman W.W., et al. Measurement of lactate in ascitic fluid: an aid in the diagnosis of peritonitis with particular reference to spontaneous bacterial peritonitis of the cirrhotic. Dig. Dis. Sci. 26:1981;1089-1094
221. Perez-Jimenez F., Roldan J., Jimenez-Alfonso J., et al. Gamma-glutamyltransferase levels in ascites of patients with cirrhosis of the liver. Acta Gastroenterol. Belg. 44:1981;565-567
222. Mishra O.P., Yusuf S., Ali Z., Nath G. Lysozyme levels for the diagnosis of tuberculous effusions in children. J. Trop. Pediatr. 46:2000;296-300
223. Braunwald E. Heart disease: a textbook of cardiovascular medicine. 1997;1478-1496 Saunders, Philadelphia
224. Corey G.R., Campbell P.T., Van Trigt P., et al. Etiology of large pericardial effusions. Am. J. Med. 95:1993;209-213
225. Meyers D.G., Meyers R.E., Prendergast T.W. The usefulness of diagnostic tests on pericardial fluid. Chest. 111:1997;1213-1221
226. Krikorian J.G., Hancock E.W. Pericardiocentesis. Am. J. Med. 65:1978;808-814
227. Cegielski J.P., Devlin B.H., Morris A.J., et al. Comparison of PCR, culture and histopathology for the diagnosis of tuberculous pericarditis. J. Clin. Microbiol. 35:1997;3254-3257
228. Spodick D.H. The technique of pericardiocentesis: when to perform it and how to minimize complications. J. Crit. Illn. 10:1995;807-812
229. Burgess L.J., Reuter H., Taljaard J.J.F., Doubell A.F. Role of biochemical tests in the diagnosis of large pericardial effusions. Chest. 121:2002;495-499
230. Mokhobo K.P. Serous effusions: an attempt at a clinical-pathological correlation. S. Afr. Med. J. 49:1974;865-868
231. Kindig J.D., Goodman M.R. Clinical utility of pericardial fluid pH determination. Am. J. Med. 75:1983;1077-1079
232. Larrieu A.J., Tyers G.F., Williams E.H., Derrick J.R. Recent experience with tuberculous pericarditis. Ann. Thorac. Surg. 29:1980;464-468
233. Koh K.K., Kim E.J., Cho C.H., et al. Adenosine deaminase and carcinoembryonic antigen in pericardial effusion diagnosis, especially in suspected tuberculous pericarditis. Circulation. 89:1994;2728-2735
234. Burgess L.J., Reuter H., Carstens M.E., et al. The use of adenosine deaminase and interferon-gamma as diagnostic tools for tuberculous pericarditis. Chest. 122:2002;900-905
235. Martinez-Vazquez J.M., Ribera E., Ocaña I., et al. Adenosine deaminase activity in tuberculous pericarditis. Thorax. 41:1986;888-889
236. Telenti M., Fdez J., de Quiros B., et al. Tuberculous pericarditis: diagnostic value of adenosine deaminase. Presse Med. 20:1991;637-640
237. Komsuoglo B., Göldelï O., Kulan K., Komsuoglu S.S. The diagnostic and prognostic value of adenosine deaminase in tuberculous pericarditis. Eur. Heart J. 16:1995;1126-1130
238. Aggeli C., Pitsavos C., Brili S., et al. Relevance of adenosine deaminase and lysozyme measurements in the diagnosis of tuberculous pericarditis. Cardiology. 94:2000;81-85
239. Dogan R., Demircin M., Sarigul A., et al. Diagnostic value of adenosine deaminase activity in pericardial fluids. J. Cardiovasc. Surg. 40:1999;501-504
240. Seino Y., Ikeda U., Kawaguchi K., et al. Tuberculous pericarditis presumably diagnosed by polymerase chain reaction analysis. Am. Heart J. 126:1993;249-251
241. Koh K.K., In H.H., Lee K.H., et al. New scoring system using tumour markers in diagnosing patients with moderate pericardial effusions. Int. J. Cardiol. 61:1997;5-13
242. Tatsuta M., Yamamura H., Yamamoto R., et al. Carcinoembryonic antigens in the pericardial fluid of patients with malignant pericarditis. Oncology. 41:1984;328-330
243. Szturmowicz M., Tomkowski W., Fijalkowska A., et al. The role of carcinoembryonic antigen (CEA) and neuron-specific enolase (NSE) evaluation in pericardial fluid for the recognition of malignant pericarditis. Int. J. Biol. Markers. 12:1997;96-101
244. Rubin R.H., Moellering R.C. Clinical, microbiologic and therapeutic aspects of purulent pericarditis. Am. J. Med. 59:1975;68-78
245. Jay S.J. Pleural effusions: I. Preliminary evaluation-recognition of the transudate. Postgrad. Med. 80:1986;170-177
246. Jay S.J. Pleural effusions: II. Definitive evaluation of the exudate. Postgrad. Med. 80:1986;181-188
247. Light R.W. Pleural effusions. Med. Clin. North Am. 61:1977;1339-1352
248. Shikamo N., Terano T., Hirai A. A case of rheumatoid pericarditis with high concentrations of interleukin-6 in pericardial fluid. Heart. 83:2000;711-712
249. Ball G.V., Schrohenloher R., Hester R. Gamma globulin complexes in rheumatoid pericardial fluid. Am. J. Med. 58:1975;123-128
250. Franco A.E., Levine H.D., Hall A.P. Rheumatoid pericarditis: report of 17 cases diagnosed clinically. Ann. Intern. Med. 77:1972;837-841
251. Lerer R.J. Cardiac tamponade as an initial finding in systemic lupus erythematosus. Am. J. Dis. Child. 124:1972;436-437
252. Wolkove N., Frank H. Lupus pericarditis. Can. Med. Assoc. J. 111:1974;1331-1333
253. Carey R.M., Coleman M., Feder A. Pericardial tamponade: a major presenting manifestation of hydralazine-induced lupus syndrome. Am. J. Med. 54:1973;84-87
254. Stein E., Dodek A., Lawson L., Rae A. Procainamide-induced lupus erythematosus: report of a case with a large pericardial effusion and fluid analysis. J. Rheumatol. 6:1979;543-548
255. Hunder G.G., Mullen B.J., McDuffie F.C. Complement in pericardial fluid of lupus erythematosus; studies in 2 patients. Ann. Intern. Med. 80:1974;453-458
256. Soloff L.A. Pericardial cellular response during the post-myocardial infarction syndrome. Am. Heart J. 82:1971;812-816
257. Ofori-Krakye S.K., Tyberg T.I., Geha A.S., et al. Late cardiac tamponade after open heart surgery: incidence, role of anticoagulants in this pathogenesis and its relationship to the postpericardiotomy syndrome. Circulation. 63:1981;1323-1328
258. Alfrey A.C., Goss J.E., Ogden D.A., et al. Uremic hemopericardium. Am. J. Med. 45:1968;391-400
259. Mann W., Millen J.E., Glauser F.L. Bloody pericardial fluid: the value of blood gas measurements. JAMA. 239:1978;2151-2152
260. Davis P.J., Jacobson S. Myxedema with cardiac tamponade and pericardial effusion of "gold paint" appearance. Arch. Intern. Med. 120:1967;615-619
261. Chan B.B., Murphy M.C., Rodgers B.M. Management of chylopericardium. J. Pediatr. Surg. 25:1990;1185-1189
262. De Wit D., Maartens G., Steyn L. A comparative study of the polymerase chain reaction and conventional procedures for the diagnosis of tuberculous pleural effusion. Tuberc. Lung Dis. 73:1992;262-267